Clinical trials
Device Safety clinical trials
Below are recruiting device safety clinical trials, each written for real people, not researchers. We’re tracking 102 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05293197RecruitingPhase 1
Safety study of repeated blood-brain barrier opening for pediatric brain tumors
This Phase 1 study tests whether a device can safely and repeatedly open the blood-brain barrier (a protective shield in the brain) in children with malignant brain tumors. It aims to help the tumor treatment work better while watching for safety issues.
ParisAges 5–17 - NCT06655636Recruiting
Testing a new robotic brace to help stroke survivors open their hand
This trial tests a wearable robotic device (ExoNET) that helps stroke survivors with hand weakness. It aims to see if the device is safe and helpful for people who had a stroke at least 8 months ago and still have trouble using their arm and hand.
Chicago, IllinoisAges 40–70 - NCT07531199Recruiting
Suture technique to reduce pressure drop after glaucoma surgery
This trial tests a new suture method during glaucoma surgery with the Preserflo device to reduce the risk of low eye pressure after the operation. It may help people with certain types of glaucoma who need surgery because their eye pressure is not controlled by medications.
AvranchesAges 18 years+ - NCT07471399Recruiting
Radiofrequency device for temporary face tightening
This study tests a radiofrequency device to tighten facial skin temporarily. It may be a treatment option for people who want non-surgical skin tightening.
SeoulAges 19–65 - NCT05702281Recruiting
Testing a new tool to place a copper IUD
This study tests whether a new inserter tool is safe and works well for placing a copper IUD called GYNEFIX. You may help researchers learn if the placement is easier and the device stays properly in place over 3 years.
GhentAges 18–48 - NCT06620757Recruiting
Short-term single blood thinner after LAmbre device implant
This study tests whether it is safe and effective to use just one blood thinner (aspirin or clopidogrel) for a short time after getting a LAmbre device implanted to close off a heart pouch that can cause strokes. It is for people with atrial fibrillation who cannot take standard blood thinners long-term.
A CoruñaAges 18–100 - NCT06246136Recruiting
Laser treatment for glaucoma during cataract surgery
This study tests a new laser treatment (ELIOS) for people with open-angle glaucoma who also need cataract surgery. It aims to see if the laser is safe and effective at lowering eye pressure while removing the cataract.
LeuvenAges 40 years+ - NCT05955846Recruiting
Testing a new cataract lens with a virtual aperture
This trial tests a specific cataract replacement lens to see how safe it is and how well it improves vision. If you have cataracts in both eyes and are good candidate for cataract surgery, this lens may help you see more clearly after surgery.
CoimbraAges 40–75 - NCT07748572Recruiting
Tracking safety and performance of brain aneurysm flow diverters
This study collects information from patients in France who are being treated for a brain aneurysm with specific flow diversion devices (p64, p48 MW, or p64 MW). The goal is to confirm that these devices are safe and work well in real-world use, which can help doctors make better treatment decisions.
AmiensAges 18 years+ - NCT07586995Recruiting
Safety and performance study of the TriClip heart valve repair device
This study tracks how well the TriClip device works and how safe it is after it's placed in your heart to repair a leaky valve. You'll attend follow-up visits so doctors can monitor your recovery and device function over time.
Phoenix, ArizonaAges 18 years+ - NCT07863960Recruiting
Light therapy for pain after cesarean section
This study tests a painless light treatment (photobiomodulation) applied to the cesarean incision to see if it reduces pain after surgery. It might help you recover with less discomfort.
Tegucigalpa, Francisco Morazán DepartmentAges 18–45 - NCT07660354Recruiting
Head lice treatment study comparing a new product to Nix
This trial tests a new head lice product (X92001483) to see how safe and effective it is compared to the standard treatment Nix. It looks at both getting rid of lice and preventing them from coming back.
Maitland, FloridaAges 1 year+ - NCT07572071RecruitingPhase 1
Cell transplant study for moderate Parkinson's disease
This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.
ShirazAges 30–70 - NCT07644338Recruiting
Brain Stimulation for Post-Traumatic Stress Disorder
This study tests a new non-invasive brain stimulation technique called temporal interference stimulation to help reduce PTSD symptoms. If you have PTSD that's lasted at least 3 months, this trial may help you or contribute to better treatments for others.
ShanghaiAges 18–50 - NCT03918408RecruitingPhase 1
Platinum eye drops and light to slow keratoconus
This Phase 1 study tests whether a specific corneal cross-linking system (called PXL-Platinum 330) is safe and effective for people with progressive keratoconus, a condition that makes the cornea thin and bulge. The goal is to slow vision changes and see how well the treatment works in the short term.
Eugene, OregonAges 12–45 - NCT07222787Recruiting
Testing a new spinal implant for lower back fusion
This trial tests a new spinal implant system (CORUS-LX) for fusing two lower back discs that are causing pain. It is meant for people with severe, long-lasting back or leg pain that hasn't improved with non-surgical treatments.
Scottsdale, ArizonaAges 18–80 - NCT07592299Recruiting
New heat-free treatment for enlarged prostate symptoms
This study tests a new device that uses electrical pulses to treat an enlarged prostate without surgery or heat. It aims to relieve urinary symptoms like weak flow and frequent urination, and may be an option if you have moderate to severe symptoms.
Germantown, TennesseeAges 45 years+ - NCT06904755RecruitingPhase 1
Stem cell therapy for liver failure through blood purification
This trial tests whether adding mesenchymal stem cells to a blood-cleaning procedure helps people with acute liver failure recover. It may reduce inflammation and improve liver function.
Guangzhou, GuangdongAges 18–65 - NCT07263451Recruiting
Testing a new treatment for small, early breast cancers
This study tests if a new treatment called IRE (irreversible electroporation) can safely treat small, early-stage breast cancers. It's for people with a single, small tumor that has not been treated yet.
Hangzhou, ZhejiangAges 18 years+ - NCT04094090RecruitingPhase 2
Corneal strengthening treatment for thinning eye shape
This Phase 2 study tests how safe and well a corneal cross-linking device (called PXL-Platinum 330) works for people with corneal ectasia (a thinning/steepening of the cornea). If you qualify, the goal is to help stop or slow further worsening of your cornea shape and improve eye stability.
San Francisco, CaliforniaAges 10 years+ - NCT07651735Recruiting
Safety and Recovery Study of Tipmed Hip Replacement
This study tracks how well people recover after hip replacement surgery using the Tipmed hip implant system. Researchers will monitor your healing and implant performance over time to ensure the device works safely and effectively.
BalıkesirAges 18 years+ - NCT06605209Recruiting
A covered stent study for iliac artery blockage
This trial tests a balloon-expandable covered stent to treat blockages in the iliac artery (a major blood vessel in your pelvis). It may be an option for people with leg pain from poor blood flow.
Beijing, Beijing MunicipalityAges 18–80 - NCT07678034Recruiting
Long-term safety study of Tipmed shoulder replacement system
This study checks how safe and effective the Tipmed shoulder replacement system is over time. It is for people who already had this specific shoulder implant during surgery.
BalıkesirAges 18 years+ - NCT07653295Recruiting
Study of Tıpmed revision hip replacement safety
This study follows patients who already had a revision hip replacement using the Tıpmed system. Researchers want to confirm the implant is safe and works well over time.
BalıkesirAges 18 years+
Hear when a new Device Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for device safety?
- Yes. Clin2 currently lists 102 recruiting device safety studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a device safety trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a device safety trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.